http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8503007-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d669af06cb2abbcd6823699582a97002 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 1983-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1985-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-8503007-A1 |
| titleOfInvention | PROCEDURE FOR OBTAINING PURE HELEBRINE |
| abstract | PROCEDURE TO OBTAIN PURE HELEBRIN CONSISTS OF: A) SUBMITTING AN EXTRACT, CONTAINING HELEBRIN, DEGREASED, IN A MIXTURE OF WATER AND 20 TO 40 PARTS BY VOLUME OF AN ALCANOL C1-C3 OR IN A MIXTURE OF WATER AND ACETONE, TO EXTRACTION WITH A MIXTURE CONSISTING OF 15 TO 35 PARTS BY VOLUME OF A C1-C3 ALCANOL AND 85 TO 65 PARTS BY VOLUME OF DICHLOROMETHANE, TRICHLOROMETHANE, OR DICHLOROETHANE OR WITH A MIXTURE OF ACETONE AND DICHLOROMETHANE, DICHLOROMETHANE, TRICHLORETHANE, DICHLOROMETHANE, TRICHLORETHANE; B) CONCENTRATE IN VACUUM THE PHASE IN CHLORINATED HYDROCARBON CONTAINING HELEBRIN; AND C) HEATING THE SYRUPUS RESIDUE SO OBTAINED TO REFLUX IN ETHANOL, UNTIL THE RESIDUE IS TOTALLY DISSOLVED AND THE FIRST HELEBRIN CRYSTALS BEGIN TO SEPARATE. IT HAS THERAPEUTIC APPLICATION BECAUSE IT IS A CARDIACTIVE COMPOUND. |
| priorityDate | 1983-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.